p.92 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay

ACC-AHA 2018 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay 連続表示で読む PDF を別タブで

画像は 92 ページを描画したものです

p.92 抽出テキスト

Kusumoto et al 2018 Bradycardia Clinical Practice Guidelines

Circulation. 2019;140:e382–e482. DOI: 10.1161/CIR.0000000000000628 August 20, 2019 e473 CLINICAL STATEMENTS AND GUIDELINES

S8.1.2.3.1-5. Greason KL, Lahr BD, Stulak JM, et al. Long-term mortality effect of early pacemaker implantation after surgical aortic valve replacement. Ann Thorac Surg. 2017;104:1259–64. S8.1.2.3.1-6. Schurr UP, Berli J, Berdajs D, et al. Incidence and risk factors for pacemaker implantation following aortic valve replacement. Interact Cardiovasc Thorac Surg. 2010;11:556–60. S8.1.2.3.1-7. Garcia-Bengochea JB, Fernandez AL, Calvelo DS, et al. Temporary epicardial left ventricular and biventricular pacing improves cardiac output after cardiopulmonary bypass. J Cardiothorac Surg. 2012;7:113. S8.1.2.3.1-8. Russell SJ, Tan C, O’Keefe P, et al. Optimized temporary biventricular pacing improves haemodynamic function after onpump cardiac surgery in patients with severe left ventricular systolic dysfunction: a two-centre randomized control trial. Eur J Cardiothorac Surg. 2012;42:e146–51. S8.1.2.3.1-9. Evonich RF, Stephens JC, Merhi W, et al. The role of temporary biventricular pacing in the cardiac surgical patient with severely reduced left ventricular systolic function. J Thorac Cardiovasc Surg. 2008;136:915–21. S8.1.2.3.1-10. Navia JL, Atik FA, Grimm RA, et al. Minimally invasive left ventricular epicardial lead placement: surgical techniques for heart failure resynchronization therapy. Ann Thorac Surg. 2005;79:1536–44; discussion -44. S8.1.2.3.1-11. Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14:e503–51. S8.1.2.3.1-12. Indik JH, Gimbel JR, Abe H, et al. 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. Heart Rhythm. 2017;14:e97–153. S8.1.2.3.1-13. Padmanabhan D, Kella DK, Mehta R, et al. Safety of magnetic

resonance imaging in patients with legacy pacemakers and defibrillators and abandoned leads. Heart Rhythm. 2018;15:228–33.

8.1.2.3.2 Mitral Valve Surgery

S8.1.2.3.2-1. Berdajs D, Schurr UP, Wagner A, et al. Incidence and pathophysiology of atrioventricular block following mitral valve replacement and ring annuloplasty. Eur J Cardiothorac Surg. 2008;34:55–61. S8.1.2.3.2-2. Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374:344–53. S8.1.2.3.2-3. Levin R, Leacche M, Petracek MR, et al. Extending the use of the pacing pulmonary artery catheter for safe minimally invasive cardiac surgery. J Cardiothor Vasc Anesthes. 2010;24:568–73. S8.1.2.3.2-4. Chikwe J, Itagaki S, Anyanwu A, et al. Impact of concomitant tricuspid annuloplasty on tricuspid regurgitation, right ventricular function, and pulmonary artery hypertension after repair of mitral valve prolapse. J Am Coll Cardiol. 2015;65:1931–8. S8.1.2.3.2-5. Gillinov AM, Gelijns AC, Parides MK, et al. Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med. 2015;372:1399–409. S8.1.2.3.2-6. Garcia-Bengochea JB, Fernandez AL, Calvelo DS, et al. Temporary epicardial left ventricular and biventricular pacing improves cardiac output after cardiopulmonary bypass. J Cardiothorac Surg. 2012;7:113. S8.1.2.3.2-7. Russell SJ, Tan C, O’Keefe P, et al. Optimized temporary biventricular pacing improves haemodynamic function after onpump cardiac surgery in patients with severe left ventricular systolic dysfunction: a two-centre randomized control trial. Eur J Cardiothorac Surg. 2012;42:e146–51. S8.1.2.3.2-8. Evonich RF, Stephens JC, Merhi W, et al. The role of temporary biventricular pacing in the cardiac surgical patient with severely reduced left ventricular systolic function. J Thorac Cardiovasc Surg. 2008;136:915–21. S8.1.2.3.2-9. Navia JL, Atik FA, Grimm RA, et al. Minimally invasive left ventricular epicardial lead placement: surgical techniques for heart failure resynchronization therapy. Ann Thorac Surg. 2005;79:1536–44; discussion-44. S8.1.2.3.2-10. Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS

expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14:e503–51. S8.1.2.3.2-11. Indik JH, Gimbel JR, Abe H, et al. 2017 HRS expert consen-

sus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. Heart Rhythm. 2017;14:e97–153. S8.1.2.3.2-12. Padmanabhan D, Kella DK, Mehta R, et al. Safety of magnetic

resonance imaging in patients with legacy pacemakers and defibrillators and abandoned leads. Heart Rhythm. 2018;15:228–33.

8.1.2.3.3 Tricuspid Valve Surgery

S8.1.2.3.3-1. Chikwe J, Itagaki S, Anyanwu A, et al. Impact of concomitant tricuspid annuloplasty on tricuspid regurgitation, right ventricular function, and pulmonary artery hypertension after repair of mitral valve prolapse. J Am Coll Cardiol. 2015;65:1931–8. S8.1.2.3.3-2. Jokinen JJ, Turpeinen AK, Pitkanen O, et al. Pacemaker therapy after tricuspid valve operations: implications on mortality, morbidity, and quality of life. Ann Thorac Surg. 2009;87:1806–14. S8.1.2.3.3-3. McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg. 2004;127:674–85. S8.1.2.3.3-4. Scully HE, Armstrong CS. Tricuspid valve replacement. Fifteen years of experience with mechanical prostheses and bioprostheses. J Thorac Cardiovasc Surg. 1995;109:1035–41. S8.1.2.3.3-5. de Cock CC, Vinkers M, Van Campe LC, et al. Long-term outcome of patients with multiple (> or=3) noninfected transvenous leads: a clinical and echocardiographic study. Pacing Clin Electrophysiol. 2000;23:423–6. S8.1.2.3.3-6. Eleid MF, Blauwet LA, Cha YM, et al. Bioprosthetic tricuspid valve regurgitation associated with pacemaker or defibrillator lead implantation. J Am Coll Cardiol. 2012;59:813–8. S8.1.2.3.3-7. Navia JL, Atik FA, Grimm RA, et al. Minimally invasive left ventricular epicardial lead placement: surgical techniques for heart failure resynchronization therapy. Ann Thorac Surg. 2005;79:1536–44; discussion-44. S8.1.2.3.3-8. Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14:e503–51. S8.1.2.3.3-9. Indik JH, Gimbel JR, Abe H, et al. 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. Heart Rhythm. 2017;14:e97–153. S8.1.2.3.3-10. Padmanabhan D, Kella DK, Mehta R, et al. Safety of magnetic

resonance imaging in patients with legacy pacemakers and defibrillators and abandoned leads. Heart Rhythm. 2018;15: 228–33.

8.1.2.4 Transcatheter Aortic Valve Replacement

S8.1.2.4-1. Piazza N, Onuma Y, Jesserun E, et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv. 2008;1:310–6. S8.1.2.4-2. Siontis GC, Juni P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol. 2014;64:129–40. S8.1.2.4-3. Boerlage-Van Dijk K, Kooiman KM, Yong ZY, et al. Predictors and permanency of cardiac conduction disorders and necessity of pacing after transcatheter aortic valve implantation. Pacing Clin Electrophysiol. 2014;37:1520–9. S8.1.2.4-4. Regueiro A, Abdul-Jawad Altisent O, Del Trigo M, et al. Impact of new-onset left bundle branch block and periprocedural permanent pacemaker implantation on clinical outcomes in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2016;9:e003635. S8.1.2.4-5. Watanabe Y, Kozuma K, Hioki H, et al. Pre-existing right bundle branch block increases risk for death after transcatheter aortic valve replacement with a balloon-expandable valve. JACC Cardiovasc Interv. 2016;9:2210–6. S8.1.2.4-6. Egger F, Nurnberg M, Rohla M, et al. High-degree atrioventricu-

lar block in patients with preexisting bundle branch block or bundle branch block occurring during transcatheter aortic valve implantation. Heart Rhythm. 2014;11:2176–82.

Downloaded from http://ahajournals.org by on October 7, 2026